Ray Dorsey
Overview
Explore the profile of Ray Dorsey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
772
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson S, Kantartjis M, Severson J, Dorsey R, Adams J, Kangarloo T, et al.
Sensors (Basel)
. 2024 Sep;
24(17).
PMID: 39275547
Prevalence estimates of Parkinson's disease (PD)-the fastest-growing neurodegenerative disease-are generally underestimated due to issues surrounding diagnostic accuracy, symptomatic undiagnosed cases, suboptimal prodromal monitoring, and limited screening access. Remotely monitored wearable...
2.
Yang Y, Yuan Y, Zhang G, Wang H, Chen Y, Liu Y, et al.
Nat Med
. 2022 Aug;
28(10):2207-2215.
PMID: 35995955
There are currently no effective biomarkers for diagnosing Parkinson's disease (PD) or tracking its progression. Here, we developed an artificial intelligence (AI) model to detect PD and track its progression...
3.
Landers M, Dorsey R, Saria S
Digit Biomark
. 2021 Oct;
5(3):216-223.
PMID: 34703976
The assessment of health and disease requires a set of criteria to define health status and progression. These health measures are referred to as "endpoints." A "digital endpoint" is defined...
4.
Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner C, Kieburtz K, et al.
Parkinsonism Relat Disord
. 2019 Feb;
62:201-209.
PMID: 30738748
Objective: To determine the feasibility, safety and tolerability of lumbar punctures (LPs) in research participants with early Parkinson disease (PD), subjects without evidence of dopaminergic deficiency (SWEDDs) and healthy volunteers...
5.
Bates G, Dorsey R, Gusella J, Hayden M, Kay C, Leavitt B, et al.
Nat Rev Dis Primers
. 2016 May;
1:15005.
PMID: 27188817
Huntington disease is devastating to patients and their families - with autosomal dominant inheritance, onset typically in the prime of adult life, progressive course, and a combination of motor, cognitive...
6.
Dorsey R, Biglan K, Eberly S, Auinger P, Brocht A, Umeh C, et al.
PLoS Curr
. 2011 Dec;
3:RRN1283.
PMID: 22139861
The safety and effectiveness of tetrabenazine in different sub-populations of Huntington disease (HD) is not known. In this study, we evaluated the safety of tetrabenazine in individuals on an antidepressant...